Bradley David, Rees Jeremy
The National Hospital for Neurology and Neurosurgery, Queen Square, Mailbox 99, London, WC1N 3BG, UK,
J Neurol. 2014 Apr;261(4):651-4. doi: 10.1007/s00415-013-7032-x. Epub 2013 Jul 16.
The management of high-grade glioma (HGG) has evolved significantly over the last decade. Patients are managed in a multidisciplinary team setting in order to ensure their care is guided by the most current evidenced based treatments. The outcome in patients with HGG, while still poor, has improved in terms of both survival and quality of life during illness. This review discusses a number of developments seen in the management of HGG over the last 5 years.
在过去十年中,高级别胶质瘤(HGG)的管理发生了显著变化。患者在多学科团队环境中接受治疗,以确保其治疗遵循最新的循证医学治疗方法。HGG患者的预后虽然仍然很差,但在生存期和患病期间的生活质量方面都有所改善。本综述讨论了过去5年中HGG管理方面的一些进展。